Measles in Children: Understanding Risks and Prevention

There is no "adult measles" distinct from childhood measles. Measles (rubeola) is caused by a single virus (MeV, genus Morbillivirus). The disease is the same regardless of age, but severity and complications differ.

Key Facts

  • Transmission: Airborne (aerosols); R₀ 12–18 (most contagious human pathogen). Infectious 4 days before to 4 days after rash onset.
  • Incubation: 10–14 days (avg 11–12).
  • Prodrome: Fever, cough, coryza, conjunctivitis (3 "C"s), Koplik spots (pathognomonic).
  • Rash: Maculopapular, starts face/hairline → spreads downward; lasts 5–6 days.

Age‑Related Severity

Prevention

  • MMR vaccine: 2 doses (12–15 mo, 4–6 yr) – 97% effective.
  • Herd immunity: Requires ≥95% 2‑dose coverage.
  • Post‑exposure prophylaxis: MMR within 72 hrs or IG within 6 days for susceptible contacts.

Global Context

Measles eliminated in Americas (2016) but resurgent due to vaccination gaps. 136,000 deaths globally (2022), mostly unvaccinated children.

Measles is one disease; age modifies outcome. Vaccination is the only reliable prevention.

Allergies - Related Articles

Health Sciences © https://www.222health.com

GroupRisk
Children <5 yearsHigh complication rate: pneumonia, otitis, diarrhea, encephalitis (1/1000), death (1–3/1000)
Adults ≥20 yearsHigher pneumonia, hospitalization, encephalitis risk; pregnancy → miscarriage, preterm birth
ImmunocompromisedSevere, prolonged, atypical (no rash); high mortality